Brand Description
BLENREP is a treatment option for adult patients with relapsed or refractory multiple myeloma, administered in combination with bortezomib and dexamethasone, and is associated with ocular toxicity risks.
Associated Domains
IAB Categories:
Health & Fitness
IAB Ad Products:
Medical and BiotechnologyHealth and Medical ServicesPharmaceuticals
IAB Categories:
Health & Fitness
IAB Ad Products:
Medical and BiotechnologyHealth and Medical ServicesPharmaceuticals
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|---|---|---|---|---|---|---|---|---|---|---|
| cmjhet | Xandr | $4.25 | 12/22/2025, 5:08:12 PM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 300x250 | 8/10 | 1340.47 KB | 8415.00 ms | |
| cmiifg | Xandr | $3.20 | 11/28/2025, 5:33:53 AM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 300x250 | 8/10 | 1342.47 KB | 8706.00 ms | |
| cmigfo | PP | $33.81 | 11/26/2025, 8:05:08 PM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 300x50 | 10/10 | 1090.64 KB | 7935.00 ms | |
| cmi7nn | PP | $2.31 | 11/20/2025, 4:37:58 PM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 320x50 | 6/10 | 1302.57 KB | 8845.00 ms | |
| cmi518 | PP | $3.17 | 11/18/2025, 8:35:06 PM | Ad Analysis: Success Domain Analysis: Success Domain Capture: Success Ad Rendering: Success Brand Mapping: Success | banner | - | 320x50 | 7/10 | 1300.61 KB | 8564.00 ms |